NEW YORK, May 19 (Reuters) - Johnson & Johnson said six-month study data showed its new experimental stent was better than Boston Scientific's Taxus at preventing re-growth of tissue within the tiny ...

ATLANTA, March 15 (Reuters) - Johnson & Johnson's Cypher drug-coated stent led to significantly fewer heart attacks, deaths and need for repeat procedures than Medtronic Inc's newer Endeavor stent ...

Johnson & Johnson intends to exit the drug-coated stent market by the end of this year-which could be good news for rivals like Fridley-based Medtronic, Inc., and Natick, Massachusetts-based Boston ...

NEW BRUNSWICK, N.J. (CBS.MW) -- Johnson & Johnson said Tuesday that a new cardiovascular device coated with an antibiotic showed "great promise" in preventing arteries from blocking up again. After ...

A 33-year-old woman visited the hospital for pain in her lower left back and painful urination. Upon examination, doctors discovered a medical device that had been left inside her body for 15 years.

Cordis Corp., the stent-making operation of Johnson & Johnson (NYSE:JNJ), saw overall sales slip nearly 7 percent and stent sales drop 35.5 percent during the third quarter. The New Brunswick, New ...

A Johnson & Johnson (NYSE:JNJ) subsidiary allegedly issued a sham recall of its drug-eluting CoStar coronary stent and spiked a distribution deal with Biotronik AG that cost the German medical device ...

SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. and Johnson & Johnson after Thursday's closing bell said the U.S. District Court in Delaware has issued rulings on two previous jury decisions in ...

Wilmington, DE - A federal jury has awarded Johnson & Johnson $271 million in damages, to be paid by Medtronic Arterial Vascular Engineering (AVE), Inc, after the same US District Court jury's found ...

BOSTON – Boston Scientific Corporation made a definitive $25 billion offer for rival medical device maker Guidant Corporation yesterday, standing by an earlier proposal that aims to scuttle a standing ...